Wikipedia:WikiProject Medicine/Translation task force AD/RTT/Simple: Difference between revisions

Revision as of 11:31, 27 March 2015

Revision as of 17:50, 22 September 2018

Line 21:

<!-- Management -->

No treatments stop or reverse its progression, though some may temporarily improve symptoms.<ref name=WHO2014/> Affected people increasingly rely on others for assistance, often placing a burden on the [[Caring for people with dementia|caregiver]]; the pressures can include social, psychological, physical, and economic elements.<ref name="pmid17662119">{{vcite journal | author = Thompson CA, Spilsbury K, Hall J, Birks Y, Barnes C, Adamson J | title = Systematic Review of Information and Support Interventions for Caregivers of People with Dementia | journal = BMC Geriatrics | volume = 7 | page = 18 | year = 2007 | pmid = 17662119 | pmc = 1951962 | doi = 10.1186/1471-2318-7-18 }}</ref> Exercise programs are beneficial with respect to [[activities of daily living]] and potentially improve outcomes.<ref name=Forb2013>{{cite journal|last1=Forbes|first1=D.|last2=Thiessen|first2=E.J.|last3=Blake|first3=C.M.|last4=Forbes|first4=S.C.|last5=Forbes|first5=S.|title=Exercise programs for people with dementia.|journal=The Cochrane databaseDatabase of systematicSystematic reviewsReviews|date=4 December 2013|volume=12|pages=CD006489|pmid=24302466|doi=10.1002/14651858.CD006489.pub3}}</ref> Treatment of behavioral problems or [[psychosis]] due to dementia with [[antipsychotic]]s is common but not usually recommended due to there often being little benefit and an increased risk of early death.<ref>{{cite web|author1=National Institute for Health and Clinical Excellence|title=Low-dose antipsychotics in people with dementia|url=https://www.nice.org.uk/advice/ktt7/resources/non-guidance-lowdose-antipsychotics-in-people-with-dementia-pdf|website=nice.org.uk|accessdate=29 November 2014}}</ref><ref>{{cite web|title=Information for Healthcare Professionals: Conventional Antipsychotics|url=http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124830.htm|website=fda.gov|accessdate=29 November 2014|date=2008-06-16}}</ref>

<!-- Epidemiology, history, society and research-->